Financial Health Assessment: COOWRY LTD (08524018)

1. Financial Health Score: F

This patient is in terminal condition. COOWRY Ltd exhibits multiple critical organ failures across all vital systems. The company is under active proposal to be struck off the register, has persistent and mounting losses, net current liabilities, and has seen two directors resign. The financial vital signs indicate a business that has haemorrhaged over £1 million in shareholder capital and is now in the final stages of corporate life.

2. Key Vital Signs

Blood Pressure (Liquidity): ⚠️ CRITICAL

The company has negative working capital — current liabilities exceed current assets by £16,283. This is the corporate equivalent of hypotension: the business cannot cover its short-term obligations from liquid resources. The situation has deteriorated by nearly £4,600 from the prior year.

Heart Rate (Revenue Generation): ⚠️ FLATLINE

• Employees: Zero (for consecutive years)
• Trade creditors: £0 (down from £1,548 in 2022)
• Turnover: Not disclosed (Income Statement not delivered — small company exemption)

The absence of trade creditors and zero employees strongly suggests this company has ceased trading operations. There is no commercial pulse detectable.

Weight (Asset Base): 📉 WASTING

The asset base is shrinking through amortisation and cash consumption — a classic case of corporate muscle wastage. The intangible assets (£63,931) represent trademarks, patents, and software that are being amortised annually with no apparent replacement or enhancement.

Cholesterol (Debt Burden): ⚠️ ELEVATED

The creditor base is dominated by "other creditors" rather than trade payables, suggesting the liabilities are primarily related to group obligations or accumulated costs rather than active trading.

Body Temperature (Profitability): 🌡️ HYPOTHERMIC

The retained earnings deficit of £1,060,678 nearly wipes out the entire share premium of £1,093,786. The shareholders have seen approximately 97% of their capital investment destroyed. The company has been loss-making consistently, with accumulated losses growing from £1,045,391 to £1,060,678 in 2023.

Historical Trajectory (Long-term Condition):

*The 2021 cash increase likely reflects a reclassification or asset disposal rather than trading income.

The pattern is unmistakable: a significant capital injection in 2017 (share premium) has been systematically consumed over six years through ongoing losses.

3. Diagnosis

Primary Conditions:

1. Corporate Terminal Illness — Active Strike-Off Proceedings The most critical symptom. The company status shows "Active — Proposal to Strike Off," meaning Companies House is in the process of removing this entity from the register. This is the corporate equivalent of a DNR (Do Not Resuscitate) order. Two directors resigned in April 2026, consistent with an orderly wind-down.

2. Chronic Loss-Making Condition The business has accumulated over £1 million in losses since inception. The 2023 loss of £15,287 continues a pattern of annual deficits that have persisted throughout the company's decade-long existence. There is no viable revenue model evident.

3. Insolvency on a Current Basis With net current liabilities of £16,283, the company is technically unable to pay its debts as they fall due from current assets — the definition of cash-flow insolvency under UK law.

4. Regulatory Non-Compliance Both annual accounts and the confirmation statement are overdue. This suggests the directors may have already disengaged from the company's administrative obligations, consistent with the strike-off process.

5. Dormant Operations Zero employees, no trade creditors, and no disclosed turnover indicate the company has effectively ceased all commercial activity. The only movements in the accounts relate to amortisation of historical intangible assets and cash consumption.

Secondary Conditions:

• Intangible Asset Dependency: 53% of total assets are intangible (trademarks, patents, software) which have limited realisable value in a wind-down scenario
• Director Loan Exposure: £17,843 in director loans remains outstanding, which directors may struggle to recover
• Group Structure: The related party exemption suggests group relationships exist, but the nature of inter-company obligations is opaque

4. Prognosis

Outcome: Inevitable corporate death.

The strike-off process, once completed, will dissolve the company. The prognosis is not a matter of whether but when. Based on the current trajectory:

• Cash runway: At the 2023 cash consumption rate of ~£6,000/year, the remaining £54,355 could theoretically sustain the entity for several more years, but this is irrelevant given the strike-off proceedings
• Recovery probability: Negligible. No trading activity, no employees, mounting accumulated losses, and active regulatory dissolution
• Creditor recovery: The £72,026 in current liabilities will likely become bad debts for creditors, as the realisable value of assets (particularly intangibles) is uncertain

5. Recommendations

Given the terminal diagnosis, treatment options are limited to palliative measures:

For the Directors:

1. Ensure proper dissolution — Cooperate with the strike-off process rather than allowing it to default, as this ensures cleaner closure and reduces personal liability risk
2. Recover director loans — The £17,843 in director loans should be prioritised for repayment before dissolution, as unsecured creditors in a strike-off typically lose their claims
3. File outstanding returns — Bring the confirmation statement and accounts up to date to avoid potential penalties or personal liability for non-compliance
4. Consider formal voluntary strike-off — If the Companies House initiative fails, the directors should file their own DS01 form for a voluntary strike-off, which provides more control over timing

For Creditors:

1. Monitor the strike-off — Any creditor can object to the strike-off within the statutory period to protect their interests
2. Assess recovery options — With net current liabilities of £16,283 and uncertain intangible asset values, recovery prospects are poor
3. Consider writing off the debt — The cost of pursuing recovery may exceed realistic recovery amounts

For Shareholders:

1. Accept capital loss — The £1,093,786 invested through share premium is effectively lost, with only £47,773 in residual equity remaining
2. Tax planning — Consult on whether the capital loss can be claimed for tax purposes against other gains
3. Corporate simplification — If this entity is part of a group, removing it simplifies the structure and reduces ongoing compliance costs

Absolute Contraindications:

• ❌ Do not invest additional capital
• ❌ Do not attempt to restart trading operations
• ❌ Do not ignore the strike-off proceedings — this could create personal liability issues for directors